Oncocyte Corporation - Common Shares, No Par Value (OCX)

Q3 2023 13F Holders as of 9/30/2023

Type / Class
Equity / Common Shares, No Par Value
Number of holders
2
Total Shares
834K
Shares change
-91M
Total reported value, excl. options
$2.72M
Value change
-$68.4M
Number of sells
-43
Price
$3.20
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.